Hydrostatic compression |
Carver 1999a (Carver and Heath 1999a) |
Young equine Mesh nonwoven PGA 10 % Fetal bovine serum; 50 μg/mL ascorbic acid |
3.4 |
0.25 |
2 |
35 |
70 |
+ GAG |
|
GAG increase strongest at 6.9 MPa for young |
= collagen II |
= # of chondrocytes |
6.9 |
+ GAG |
|
+ collagen II |
= # of chondrocytes |
Adult equine Mesh nonwoven PGA 10 % Fetal bovine serum; 50 μg/mL ascorbic acid |
3.4 |
+ GAG |
|
Collagen II increase strongest at 6.9 MPa for young and adult |
+ collagen II |
= # of chondrocytes |
6.9 |
= GAG |
|
+ collagen II |
= # of chondrocytes |
Carver 1999b (Carver and Heath 1999b) |
Young equine Mesh nonwoven PGA 10 % Fetal bovine serum; 50 μg/mL ascorbic acid |
3.44 |
0.25 |
2 |
35 |
70 |
+ GAG |
|
+ E- modulus |
+ collagen |
= # of chondrocytes |
Direct compression |
Démarteau 2003 (Démarteau et al. 2003) |
Human Mesh PEGT/PBT Foam 10 % Fetal bovine serum; growth factor TGF-β1, FGF-2, PDGFbb |
0.3-0.6* (5 %) |
0.1 |
4 |
3 |
12 |
+ GAG |
= Sox9 |
Measured peak loading 0.018 MPa |
= aggrecan |
= collagen II |
Hilz 2014 (Hilz et al. 2014) |
Bovine, Mesh Polyurethane 25 % Fetal calf serum;50 μg/mL L-ascorbic acid |
1.2-2.4* (20 %) |
1 |
2** |
21 |
16 |
+ GAG |
=Sox9 |
|
+ aggrecan |
+collagen II |
+ collagen II |
El-ayoubi 2011 (El-Ayoubi et al. 2011) |
Canine, Mesh poly-L-Lactide 10 % Fetal bovine serum |
0.6-1.2* (10 %) |
1 |
3 |
14 |
42 |
+ # of cells |
|
|